ABCL
USDAbCellera Biologics Inc. Common Shares
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$3.200
High
$3.310
Low
$3.080
Volume
8.00M
Company Fundamentals
Market Cap
940.2M
Industry
Biotechnology
Country
Canada
Trading Stats
Avg Volume
4.49M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Truist Securities Maintains Buy on AbCellera Biologics, Lowers Price Target to $10
Truist Securities analyst Robyn Karnauskas maintains AbCellera Biologics with a Buy and lowers the price target from $28 to $10.
AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause
AbCellera anticipates starting the Phase 1 clinical trial for ABCL635 in Q3 2025 AbCellera (NASDAQ:ABCL) today announced it has received a No Objection Letter (NOL) from Health Canada authorizing its Clinical Trial
AbCellera Reports Q1 2025 Business Results
AbCellera (NASDAQ:ABCL) today announced financial results for the first quarter of 2025. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. "After completion of a
AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025
Preclinical data on AbCellera's PSMA x CD3 T-cell engagers demonstrate potent anti-tumor activity and potential to further enhance function through costimulatory strategies AbCellera (NASDAQ:ABCL) today announced new
Related Stocks
DRMAW
Dermata Therapeutics Inc. Warrant
TECH
Bio-Techne
DNN
Denison Mines Corp Ordinary Shares (Canada)
RNAZ
TransCode Therapeutics Inc.
AACG
ATA Creativity Global American Depositary Shares
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.